Global Site Settings

<p>Earnings announcement for the 3rd quarter FY2022 (Feb 2, 2023)</p>


A passion for sustainability is driving industry-leading CO2 savings in Austria

<p><a class="chevron-after" href="https://www.takeda.com/newsroom/" target="_blank">GO TO NEWSROOM</a><strong><span class="red-text"><br /></span></strong></p>

RECENT NEWS

<p>TSE Code 4502<br />TSE Prime Market<a><br /></a></p>

STOCK PRICE

Andy Plump discusses maintaining trust in science.

<span class="active">Corporate Responsibility</span>

<table style="width: 100%; border-collapse: collapse; border-style: hidden; height: 194px;" border="0">
<tbody>
<tr style="height: 118px; background-color: #edf2f4;">
<td style="width: 100%; height: 118px; padding: 30px;">
<h4><a href="https://www.takeda.com/investors/financial-results/">Earnings announcement for the 3rd quarter FY2022 (February 2, 2023<span class="chevron-after" style="position: relative;">)</span></a></h4>
</td>
</tr>
<tr style="height: 40px;">
<td style="width: 100%; height: 40px; padding: 30px;">
<h4><span class="chevron-after" style="position: relative;"><a href="https://www.takeda.com/investors/ir-events/">41<sup>st</sup> Annual J.P. Morgan Healthcare Conference (4:30pm &ndash; 5:10pm PST on January 9, 2023)</a></span></h4>
</td>
</tr>
<tr style="height: 18px; background-color: #edf2f4;">
<td style="width: 100%; height: 18px; padding: 30px;">
<h4><span class="chevron-after" style="position: relative;"><a href="https://www.takeda.com/investors/shareholders-meetings/">146th Ordinary General Meeting of Shareholders (June 29, 2022)</a></span></h4>
</td>
</tr>
<tr style="height: 18px;">
<td style="width: 100%; height: 18px; padding: 30px;">
<h4><span class="chevron-after" style="position: relative;"><a href="https://www.natpara.com/recall#/latest-updates">Information for US Patients Regarding the NATPARA Recall in the US</a></span></h4>
</td>
</tr>
<tr style="height: 18px; background-color: #edf2f4;">
<td style="width: 100%; height: 18px; padding: 30px;">
<h4><span class="chevron-after" style="position: relative;"><a href="https://www.takeda.com/investors/stock-and-shares/procedure/">ADS Helpline</a></span></h4>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>

Thank you for subscribing.
Please check your inbox to verify your email address.

**Help us understand more about you and what you need.**  
Complete a short survey and share your communication preferences.

[Share your thoughts >](/investors/retail-investors/ri-survey)

<p style="text-align: right;">Takeda's focus on health equity; Rare Disease Day 2023</p>


<h4 style="text-align: center;">Welcome to the Global<br>Corporate Website for Takeda</h4>

If you are looking for specific information,
please visit our country/region website. 



HOME

T-CiRA

About T-CiRA

Leaders Message

What we do

Portfolios

Projects

Inside T-CiRA

Research Achievements

Future of iPSC

What We Do

Newsroom

Dr.Tomoya Uchimura in Intractable Muscular Disease Project recipient of Travel & Merit Award to ISSCR 2020

<p>Dr.Tomoya Uchimura (Center for iPS Cell Research and Application, Kyoto University, Sakurai lab) in Intractable Muscular Disesase Project received a recipient of Travel &amp; Merit Award by International Scoiety of Stem Cell Research (ISSCR) 2020. &nbsp;Intractable Muscular Disease Project is developing novel therapeutic drugs for intractable muscular diseases such as muscular dystrophy and investigate muscular disease models using patient-derived iPSCs as a tool for disease modeling and drug screening.<br />Presentation title: Recapitulating functional phenotypes of DMD using patient-derived iPSCs<br /><br />ISSCR 2020 Virtual, 23-27 June</p>
<p>ISSCR website：<a href="https://www.isscr.org/meetings-events/annual-meetings/isscr-2020-virtual" target="_blank" rel="noopener">https://www.isscr.org/meetings-events/annual-meetings/isscr-2020-virtual</a></p>
<p>Project details：<a href="https://www.takeda.com/49de3e/siteassets/system/what-we-do/t-cira/research/hidetoshi-sakurai_ever2.pdf" target="_blank" rel="noopener">https://www.takeda.com/49de3e/siteassets/system/what-we-do/t-cira/research/hidetoshi-sakurai_ever2.pdf</a></p>

Global News Releases

<p><small>HTTP 404 Error</small></p>
<p>We're sorry, the page you are looking for can't be found.</p>
<hr />
<p>&nbsp;</p>
<p style="display: inline-block;"><a title="HOME PAGE" href="https://www.takeda.com/" target="_top">HOME&nbsp;</a>&nbsp;|&nbsp;<a title="CONTACT US" href="https://www.takeda.com/who-we-are/contact-us/" target="_top">CONTACT US</a>&nbsp;|</p>
<a href='https://www.takeda.com/worldwide/' class='countryselector__url'><svg class='footer__country__icon icon__text icon--red'><use xlink:href='/Themes/Shared/ui/svg/takeda.svg#icon-earth'></use></svg>SELECT A COUNTRY SITE</a>
<div class="page-layout--iefix">&nbsp;</div>

Search

Greetings,

I found this interesting and I would like to share it with you.



<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K75R39" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>


<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5XBTH5B"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>

version

website_name

cluster

page_id

page_name

page_language

page_type

page_url

section

page_error

target_group

ip_address

Exceeds limit of {0}MB. Please lower the size for upload.